Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate + atorvastatin fixed-dose combination versus atorvastatin or fenofibrate alone in mixed dyslipidemia
ISRCTN14937154Phase 3Completed
- Sponsor
- Laboratorios Senosiain
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of atorvastatin and fenofibrate in combined dyslipidaemia, sponsored by Laboratorios Senosiain. Primary endpoint: Reduction in non-HDL cholesterol. Started Oct 2016; status: completed.
02
Drugs
atorvastatinfenofibrate
03
Conditions
combined dyslipidaemia
Beyond the preview
Go deeper on ISRCTN14937154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14937154.